25/08/2026
Our liver research experts in the spotlight over £2.7 million national research programme using weight loss drug
Researchers at our NIHR Biomedical Research Centre (BRC) in Nottingham are working with experts in Plymouth to find out whether a popular weight loss drug can help patients with alcohol dependency and obesity - two of the biggest causes of liver disease.
The CURB research trial is a £2.7 million national funded research programme to investigate whether a weight-loss injection (semaglutide, also known as Wegovy) can help patients living with alcohol dependency and obesity, two of the biggest causes of liver disease.
The story about this research has been catching the attention of the media. Professor Guru Aithal, Co-Lead of the CURB trial and Deputy Director of the NIHR BRC in Nottingham, was recently interviewed by BBC East Midlands TV.
This research was also the subject of a BBC News online story: https://www.bbc.co.uk/news/articles/c9q98n241g5o
Professor Aithal was also a guest on Verity Cowley’s BBC Radio Nottingham show. He discussed the urgent need for new treatments for alcohol dependency, obesity and liver disease.
His interview is on the BBC Sounds App and can be accessed via the link below, starting around 1 hour 14 minutes into the show, and finishing at approximately 1 hour 21 minutes
https://www.bbc.co.uk/sounds/play/m00308cx